| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 04/15/2004 | US20040072749 Composition for the elimination of autoreactive b-cells |
| 04/15/2004 | US20040072748 Methods and compositions for the treatment and prevention of Staphylococcus and other bacterial infections |
| 04/15/2004 | US20040072340 Use of peptide vectors to improve the immune response to antigens |
| 04/15/2004 | US20040072314 Isolating and purifying therapeutic polypeptide using undulating solid support comprising polyethersulphone |
| 04/15/2004 | US20040072299 Multiple cytokine protein complexes |
| 04/15/2004 | US20040072290 Transgenic cells expressing anti-human squamous-cell carcinoma monoclonal antibody with enhanced antibody dependent cellular cytotoxicity (ADCC); drug targeting and delivery |
| 04/15/2004 | US20040072265 Using tumor antigen CDNA probes to diagnose and treat brain disorders; antiproliferative/antitumor agents |
| 04/15/2004 | US20040072256 Nk cells activiating receptors and their therapeutic and diagnostic uses |
| 04/15/2004 | US20040072224 Comprises therapeutic polypeptide for prevention and treatment of mycobacterial infections, cancers and immunological disorders gene and immunotherapy |
| 04/15/2004 | US20040072220 Neurotonin and use thereof |
| 04/15/2004 | US20040072196 Novel serpentine transmembrane antigens expressed in human cancers and uses therefor |
| 04/15/2004 | US20040072192 Cancer-linked genes as targets for chemotherapy |
| 04/15/2004 | US20040072189 Diagnosing cancer via presence of osteopontin in epithelial cells; genetic vaccines; antitumor agents |
| 04/15/2004 | US20040072177 Novel human serine-threonine kinase |
| 04/15/2004 | US20040072174 Calpain protease 12 |
| 04/15/2004 | US20040072171 Screening for regulatory factors of neurofibromatosis (NF2); antitumor agents |
| 04/15/2004 | US20040072169 Comprises nucleotide sequences coding polypeptide for exogenous expression in avian embryonic stem cells; bioreactors |
| 04/15/2004 | US20040072162 Hiv peptides and nucleic acids encoding them for diagnosis and control of hiv infection |
| 04/15/2004 | US20040072153 Pasteurella neuraminidase coding sequences, compositions and diagnostic methods |
| 04/15/2004 | US20040072152 Screening blood and identifying immunologically active antigen of herpes simplex virus (HSV) which attacks skin; diagnosing viral infection; viricides |
| 04/15/2004 | US20040072140 Freeze dried lymphocytes for vaccine development; immunotherapy |
| 04/15/2004 | US20040071739 Methods of preparing an anti-tumor vaccine |
| 04/15/2004 | US20040071738 Hypo-allergenic pollen protein treated with thioredoxin, nicotinamide adenine dinucleotide phosphate- thioredoxin reductase (NTR) and reduced nicotinamide adenine dinucleotide phosphate (NADPH) |
| 04/15/2004 | US20040071737 Polysaccharides and/or glycopeptides preparable from keratinophilic fungi and yeasts; vaccines, immunomodulators, and antiallergens; precipitation and separation of supernatant; treatment with mineral or organic acid |
| 04/15/2004 | US20040071735 Bone and muscular disorder treatment |
| 04/15/2004 | US20040071734 Novel vaccine |
| 04/15/2004 | US20040071733 Baculovirus vector vaccine |
| 04/15/2004 | US20040071731 Chimeric protein comprising non-toxic pseudomonas exotoxin a and type iv pilin sequences |
| 04/15/2004 | US20040071730 Polypeptides and polynucleotides; genetic engineering; medical diagnosis |
| 04/15/2004 | US20040071729 Comprising amino acid sequences of streptococcal matrix adhesion (Ema) polypeptides |
| 04/15/2004 | US20040071728 Vaccine for congenital tremors in pigs |
| 04/15/2004 | US20040071727 Method of vaccinating vertebrates |
| 04/15/2004 | US20040071725 Administered with target antigens to treat infections; anticarcinogenic and antitumor agents; genetic engineering |
| 04/15/2004 | US20040071724 Heat shock protein-based vaccines and immunotherapies |
| 04/15/2004 | US20040071723 Heat shock protein-based vaccines and immunotherapies |
| 04/15/2004 | US20040071722 Heat shock protein-based vaccines and immunotherapies |
| 04/15/2004 | US20040071721 A fusion protein of antigen and heat shock protein; DNA therapy promoting gene expression in mammal cells, treating infectious diseases and cancers, tumors; polynucleotide construct vectors |
| 04/15/2004 | US20040071720 A fusion protein of antigen and heat shock protein; DNA therapy promoting gene expression in mammal cells, treating infectious diseases and cancers, tumors; polynucleotide construct vectors |
| 04/15/2004 | US20040071718 Local nasal immunotherapy for allergen-induced airway inflammation |
| 04/15/2004 | US20040071717 Recombinant DNA encoding the major allergen of plantago lanceolata pollen, Pla I 1, and applications thereof |
| 04/15/2004 | US20040071716 An adjuvant is used in vaccine formulation, comprising a polymeric emulsifier Arlacel" or ATLOX"; stable, low viscosity |
| 04/15/2004 | US20040071715 A capsule comprising a formaldehyde-treated antigens dispersed within a biocompatible polymer and an amino acid stabilizer as antiagglomerants; sustained release |
| 04/15/2004 | US20040071714 A gene expressed polypeptide is used in food, for treating food allergy |
| 04/15/2004 | US20040071713 A protein is obtained from gene expression of Pseudomonas aeruginosa, molecular weight range from 13 kDa to 80 kDa, purification, antibody, immunization with vaccine antigens, treating bacterial infections |
| 04/15/2004 | US20040071711 Imaging, diagnosis and treatment of disease |
| 04/15/2004 | US20040071710 Human monoclonal antibody against hepatitis c virus e2 glycoprotein |
| 04/15/2004 | US20040071709 Corona-virus-like particles comprising functionally deleted genomes |
| 04/15/2004 | US20040071706 An antibody for treating Crohn's disease and ulcerative colitis, inhibit the transduction of biological activity of cytokine, B-cell differentiation factors |
| 04/15/2004 | US20040071703 A mixture comprising decorin binding protein and fibronectin binding protein, for treating Lyme disease in animal |
| 04/15/2004 | US20040071699 An antagonists, or agonists, producing antibodies, used as immunotherapy treating allergy, acquired immune deficiency syndrome, autoimmune diabetes, thyroiditis |
| 04/15/2004 | US20040071698 Human anti-epidermal growth factor receptor single-chain antibodies |
| 04/15/2004 | US20040071697 Reducing epithelial toxicity during cancer therapy |
| 04/15/2004 | US20040071693 Humanised antibodies |
| 04/15/2004 | US20040071692 Minimizes toxicity to normal tissue; high therapeutic index |
| 04/15/2004 | US20040071691 Including compatible solute; enhancing effectiveness of protein containing active material; reducing cytotoxic activity |
| 04/15/2004 | US20040071690 High avidity polyvalent and polyspecific reagents |
| 04/15/2004 | US20040071689 Administering library then collecting and analyzing sample of biological target material |
| 04/15/2004 | US20040071671 Cell therapy method for the treatment of tumors |
| 04/15/2004 | US20040071661 Synthetic viruses and uses thereof |
| 04/15/2004 | US20040071658 Vaccine immunotherapy for immune suppressed patients |
| 04/15/2004 | US20040071657 Drawing to target site using chemokine, cytokine and/or somatostatin receptor agonist localization factors |
| 04/15/2004 | US20040071656 Modulation of heat-shock-protein-based immunotherapies |
| 04/15/2004 | US20040071654 Delivering labile agents; buffering effect; transfecting nucleic acids; nontoxic |
| 04/15/2004 | CA2501040A1 Genetically engineered toxoplasma gondii p30 antigen, improved antigen cocktail and uses thereof |
| 04/15/2004 | CA2500960A1 Therapeutic uspa1-derived peptides |
| 04/15/2004 | CA2500955A1 Optimized multi-epitope constructs and uses thereof |
| 04/15/2004 | CA2500911A1 Composition for vaccination |
| 04/15/2004 | CA2500723A1 Use of il-2 receptor antibodies to prevent toxicity associated with amphotericin b antimycotic therapy |
| 04/15/2004 | CA2500715A1 Hla binding peptides and their uses |
| 04/15/2004 | CA2500673A1 Hbv mutations associated with reduced susceptibility to adefovir |
| 04/15/2004 | CA2500661A1 Anti-cancer and anti-infectious disease compositions and methods for using same |
| 04/15/2004 | CA2500652A1 Diagnosis and monitoring of diseases |
| 04/15/2004 | CA2500538A1 Method for treating or preventing metastasis of colorectal cancers |
| 04/15/2004 | CA2500531A1 Method for treating or preventing metastasis of colorectal cancers |
| 04/15/2004 | CA2500470A1 Method for diagnosing chronic myeloid leukemia |
| 04/15/2004 | CA2500433A1 Recombinant intracellular pathogen immunogenic compositions and methods for use |
| 04/15/2004 | CA2500405A1 Genes and polypeptides relating to human myeloid leukemia |
| 04/15/2004 | CA2500401A1 Antigenic peptides |
| 04/15/2004 | CA2500093A1 Dna vaccine encoding at least two nonstructural early proteins of papillomavirus |
| 04/15/2004 | CA2499837A1 Human papillomavirus polypeptides and immunogenic compositions |
| 04/15/2004 | CA2499477A1 Prevention of primary sjogren's syndrome by ica69 deficiency |
| 04/15/2004 | CA2498854A1 Novel mhc ii associated peptides |
| 04/15/2004 | CA2498829A1 Use of protein tyrosine phosphatase inhibitors for prevention and/or treatment of cancer |
| 04/15/2004 | CA2498823A1 Vaccines containing viruses involved in avian malabsorption syndrome and methods of administration therefor |
| 04/15/2004 | CA2498631A1 Use of a33 antigens and jam-it |
| 04/15/2004 | CA2496508A1 Cancer therapy using beta glucan and antibodies |
| 04/14/2004 | EP1408333A2 Diagnosis and treatment of Alzheimer's disease |
| 04/14/2004 | EP1408114A1 Modular antigen-transporter-molecules (MAT-molecules) for modulating immune responses, corresponding constructs and methods and uses thereof |
| 04/14/2004 | EP1408112A1 MONOCLONAL ANTIBODY BINDING TO MT4−MMP CATALYTIC DOMAIN |
| 04/14/2004 | EP1408048A1 Vaccines of enhanced immunogenicity, and methods for preparing such vaccines |
| 04/14/2004 | EP1407795A2 Nasal delivery devices |
| 04/14/2004 | EP1407781A1 Anti-lymphotoxin-beta receptor antibodies as anti-tumor agents |
| 04/14/2004 | EP1407039A2 Anti-arthropod vector vaccines methods of selecting and uses thereof |
| 04/14/2004 | EP1407033A1 Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (mva) |
| 04/14/2004 | EP1407023A2 Group b streptococcus antigens and corresponding dna fragments |
| 04/14/2004 | EP1407019A2 Intestinal proteins |
| 04/14/2004 | EP1407018A2 Human proteins, polynucleotides encoding them and methods of using the same |
| 04/14/2004 | EP1407015A2 Compositions and methods relating to breast specific genes and proteins |
| 04/14/2004 | EP1407014A2 Screening method for attenuating or virulence defective microbial cells |
| 04/14/2004 | EP1407013A1 Mutations in ion channels |